Readoutin 13d
Sanofi Pasteur, a Sanofi Company — PCV21
Phase 3 primary completion: Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents.
- Date
- Dec 2026
- Type
- Readout
- Indication
- Pneumococcal Infections